69 related articles for article (PubMed ID: 1843147)
1. [An increased frequency of allele A6 of the proto-oncogene HRAS1 in cancer patients].
Nikiforova IF; Pluzhnikova GF; Serova OM; Kniazev PG
Vopr Onkol; 1991; 37(6):700-5. PubMed ID: 1843147
[TBL] [Abstract][Full Text] [Related]
2. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
[TBL] [Abstract][Full Text] [Related]
3. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
4. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
[TBL] [Abstract][Full Text] [Related]
5. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
7. [Increased risk of occurrence of pulmonary adenocarcinoma in man is associated with the presence of rare alleles of the Hras1 minisatellite].
Gaspar'ian AV; Zborovskaia IB; Mukeriia AF; Tatosian AG; Zaridze DG
Genetika; 1998 Nov; 34(11):1537-41. PubMed ID: 10096029
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
9. [Study of HRas1 minisatellite frequencies in children with thyroid papillary cancer].
Iarmolinskiĭ DG; Kartel NA; Ermak G; Demidchik IuE; Figge J
Tsitol Genet; 2004; 38(1):9-14. PubMed ID: 15098441
[TBL] [Abstract][Full Text] [Related]
10. Hras1 VNTR alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors.
Lindstedt BA; Ryberg D; Zienolddiny S; Khan H; Haugen A
Anticancer Res; 1999; 19(6C):5523-7. PubMed ID: 10697610
[TBL] [Abstract][Full Text] [Related]
11. The HRAS1 variable number of tandem repeats and risk of breast cancer.
Tamimi RM; Hankinson SE; Ding S; Gagalang V; Larson GP; Spiegelman D; Colditz GA; Krontiris TG; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1528-30. PubMed ID: 14693748
[TBL] [Abstract][Full Text] [Related]
12. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
13. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
15. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
16. [Molecular nature of oncogene HRAS1 damage in human breast carcinoma: G----T transversion in codon 12 of one allele during deletion of other allele].
Kniazev PG; Serova OM; Babenko VI; Nikiforova IF; Gol'tseva AA; Pluzhnikova GF; Plutalov OV; Berlin IuA; Shvarts EI
Bioorg Khim; 1990 Mar; 16(3):419-23. PubMed ID: 2192714
[No Abstract] [Full Text] [Related]
17. Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1.
Yoshimoto K; Iizuka M; Iwahana H; Yamasaki R; Saito H; Saito S; Sekiya T
Cancer Res; 1989 May; 49(10):2716-21. PubMed ID: 2565762
[TBL] [Abstract][Full Text] [Related]
18. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
19. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of poly(ADP-ribose) polymerase pseudogene polymorphism and association with susceptibility to lung cancer in Chinese people].
Tang L; Ren Z; Zhuang Z; Liu X; Su Z; Huang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):124-6. PubMed ID: 11941587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
